Apremilast for the treatment of palmo‐plantar non‐pustular psoriasis: A real‐life single‐center retrospective study-Reference-Cited by-同舟云学术

Apremilast for the treatment of palmo‐plantar non‐pustular psoriasis: A real‐life single‐center retrospective study

Published:2021-12-26 Issue:2 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Pavia Giulia¹²^ORCID,Gargiulo Luigi¹²^ORCID,Cortese Andrea¹²^ORCID,Valenti Mario¹²^ORCID,Sanna Federica²,Borroni Riccardo G.¹²,Costanzo Antonio¹²,Narcisi Alessandra²

Affiliation:

1. Dermatology Unit, Department of Biomedical Sciences Humanitas University Milan Italy

2. Dermatology Unit Humanitas Clinical and Research Center – IRCCS Milan Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15253

Reference12 articles.

1. Palmoplantar psoriasis: A phenotypical and clinical review with introduction of a new quality-of-life assessment tool

2. Palmoplantar Psoriasis- Ahead in the Race-A Prospective Study from a Tertiary Health Care Centre in South India

3. Retrospective analysis of the treatment of psoriasis of the palms and soles

4. Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report;Journal of Dermatological Treatment;2024-02-20

2. Psoriasis und Beruf: Retrospektive Evaluation von Klinik und Risikofaktoren eines Kollektivs der tertiären Individualprävention;Dermatologie in Beruf und Umwelt;2023-04-01

3. Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis;Dermatology and Therapy;2023-01-06

4. Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria – results the APPRECIATE study;Therapeutic Advances in Chronic Disease;2023-01

5. Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study— IL PSO ( Italian landscape psoriasis );Journal of the European Academy of Dermatology and Venereology;2022-10-05